Experts break down key multiple myeloma data and trends from the 23rd Annual IMS Meeting.
Etentamig, Iberdomide, and Long-Term PERSEUS Data Headline Key Myeloma Findings From IMS 2026
Experts break down key multiple myeloma data and trends from the 23rd Annual IMS Meeting.